On Invalid Date, Biosig Technologies (NASDAQ: BSGM) reported Q4 2023 earnings per share (EPS) of -$0.65, up 51.13% year over year. Total Biosig Technologies earnings for the quarter were -$6.05 million. In the same quarter last year, Biosig Technologies's earnings per share (EPS) was -$1.33.
As of Q2 2024, Biosig Technologies's earnings has grown year over year. Biosig Technologies's earnings in the past year totalled -$29.05 million.
What is BSGM's earnings date?
Biosig Technologies's earnings date is Invalid Date. Add BSGM to your watchlist to be reminded of BSGM's next earnings announcement.
What was BSGM's revenue last quarter?
On Invalid Date, Biosig Technologies (NASDAQ: BSGM) reported Q4 2023 revenue of $12.00 thousand up 91.11% year over year. In the same quarter last year, Biosig Technologies's revenue was $135.00 thousand.
What was BSGM's revenue growth in the past year?
As of Q2 2024, Biosig Technologies's revenue has grown -93.71% year over year. This is 103.17 percentage points lower than the US Medical Devices industry revenue growth rate of 9.47%. Biosig Technologies's revenue in the past year totalled $18.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.